Synaptogenix (SNPX) Institutional Ownership $5.99 -0.34 (-5.37%) As of 08/1/2025 Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Synaptogenix (NASDAQ:SNPX)CurrentInstitutional OwnershipPercentage10.34%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$37.63KNumber ofInstitutional Sellers(last 12 months)0 Get SNPX Insider Trade Alerts Want to know when executives and insiders are buying or selling Synaptogenix stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SNPX Institutional Buying and Selling by Quarter Synaptogenix Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/12/2025Geode Capital Management LLC10,844$39K0.0%N/A0.797% 2/3/2023Cannell & Co.30,000$35K0.0%-60.6%0.413% 1/11/2023Platform Technology Partners25,138$29K0.0%+56.8%0.346% 8/12/2022Ikarian Capital LLC121,191$614K0.1%-20.9%1.772% 5/3/2022Platform Technology Partners16,032$124K0.1%-25.0%0.235% 2/14/2022Diametric Capital LP30,521$260K0.2%-17.2%0.457% 2/7/2022 Orion Capital Management LLC4,000$34K0.0%N/A0.060% 2/1/2022Platform Technology Partners21,375$182K0.1%-34.2%0.320% 9/17/2021Virtu Financial LLC14,259$140K0.0%N/A0.232% 8/18/2021Ikarian Capital LLC300,000$2.96M0.2%N/A4.968% 8/17/2021Worth Venture Partners LLC73,909$642K0.2%N/A1.224% 8/17/2021Boothbay Fund Management LLC34,079$336K0.0%N/A0.564% 8/16/2021Diametric Capital LP21,901$216K0.2%N/A0.363% 8/12/2021 AIGH Capital Management LLC316,945$2.83M0.5%N/A5.248% 8/10/2021CM Management LLC10,000$99K0.1%N/A0.166% 8/5/2021Platform Technology Partners32,500$320K0.1%N/A0.538% (Data available from 1/1/2016 forward) SNPX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SNPX shares? During the previous two years, the following institutional investors and hedge funds held shares of Synaptogenix shares: Geode Capital Management LLC ($39K).Learn more on Synaptogenix's institutional investors. What percentage of Synaptogenix's stock is owned by institutional investors? 10.34% of Synaptogenix's stock is owned by institutional investors. Learn more on SNPX's institutional investor holdings. Which institutional investors have been buying Synaptogenix's stock? The following institutional investors have purchased Synaptogenix's stock in the last 24 months: Geode Capital Management LLC ($10.84K). How much institutional buying is happening at Synaptogenix? Institutional investors have bought a total of 10,844 shares in the last 24 months. This purchase volume represents approximately $37.63K in transactions. Related Companies Xilio Therapeutics Major Shareholders Incannex Healthcare Major Shareholders Rani Therapeutics Major Shareholders Clearside Biomedical Major Shareholders Synergy CHC Major Shareholders Mersana Therapeutics Major Shareholders Sol-Gel Technologies Major Shareholders ALX Oncology Major Shareholders Dyadic International Major Shareholders Estrella Immunopharma Major Shareholders This page (NASDAQ:SNPX) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synaptogenix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Synaptogenix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
